Your session is about to expire
← Back to Search
Family Navigation for Child Mental Health Access
N/A
Waitlist Available
Led By Emily Feinberg, ScD, CPNP
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Children who are 3-12 years old and screen positive on the Pediatric Symptom Checklist-17 (PSC-17) (6-12 years)
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 months
Awards & highlights
Study Summary
This trial will test different components of an intervention called Family Navigation (FN) to see which ones are most effective in helping low income and minority families access mental health services for their children. The goal is to develop a more efficient and cost-effective FN model.
Who is the study for?
This trial is for children aged 3-12 who may have mental health concerns, identified either through a screening tool or during pediatric visits. It's not for kids already in specialty care, those with active psychosis, or immediate safety issues needing emergency services.Check my eligibility
What is being tested?
The study tests different ways to help families get mental health services for their kids. This includes clinic and community visits, technology support, and personalized scheduling. They're using a special method to find the most effective yet resource-saving approach.See study design
What are the potential side effects?
Since this trial involves service interventions rather than medications, traditional side effects are not applicable. However, there could be potential stress or inconvenience associated with attending various types of appointments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child is between 3-12 years old and has emotional or behavioral issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Access to services [Yes/No]
Change in Pediatric Symptom Checklist-17 (PSC-17)
Change in the Survey of Well-being of Young Children (SWYC)
+1 moreSecondary outcome measures
Change in Family Resource Scale (FRS)
Change in Patient Health Questionnaire-2 [PHQ-2}
Change in the Parental Attitudes Toward Psychological Services Inventory (PATPSI)
+3 moreTrial Design
16Treatment groups
Experimental Treatment
Group I: Group 9- DonkeyExperimental Treatment4 Interventions
Clinic and community visits, usual care coordination, standard pediatric surveillance, and structured visits
Group II: Group 8- DogExperimental Treatment4 Interventions
Clinic-based visit, technology-enhanced care coordination, enhanced pediatric surveillance, and individually-tailored visits
Group III: Group 7- CatExperimental Treatment4 Interventions
Clinic-based visit, technology-enhanced care coordination, standard pediatric surveillance, and individually-tailored visits
Group IV: Group 6- LlamaExperimental Treatment4 Interventions
Clinic-based visit, usual care, enhanced pediatric surveillance, and individually-tailored visits
Group V: Group 5- SheepExperimental Treatment4 Interventions
Clinic-based visit, usual care, standard pediatric surveillance, and individually-tailored visits
Group VI: Group 4- PigExperimental Treatment4 Interventions
Clinic-based visit, technology-enhanced care coordination, enhanced pediatric surveillance, and structured visits
Group VII: Group 3- HorseExperimental Treatment4 Interventions
Clinic-based visit, technology-enhanced care coordination, standard pediatric surveillance, and structured visits
Group VIII: Group 2- CowExperimental Treatment4 Interventions
Clinic-based visit, usual care, enhanced pediatric surveillance, and structured visits
Group IX: Group 16- GiraffeExperimental Treatment4 Interventions
Clinic and community visits, technology-enhanced care, enhanced pediatric surveillance, and individually-tailored visits
Group X: Group 15- ElephantExperimental Treatment4 Interventions
Clinic and community visits, technology-enhanced care, standard pediatric surveillance, and individually-tailored visits
Group XI: Group 14- ZebraExperimental Treatment4 Interventions
Clinic and community visits, usual care coordination, enhanced pediatric surveillance, and individually-tailored visits
Group XII: Group 13- MonkeyExperimental Treatment4 Interventions
Clinic and community visits, usual care coordination, standard pediatric surveillance, and individually-tailored visits
Group XIII: Group 12- LionExperimental Treatment4 Interventions
Clinic and community visits, technology enhanced care coordination, enhanced pediatric surveillance, and structured visits
Group XIV: Group 11- TigerExperimental Treatment4 Interventions
Clinic and community visits, technology enhanced care coordination, standard pediatric surveillance, and structured visits
Group XV: Group 10- BearExperimental Treatment4 Interventions
Clinic and community visits, usual care coordination, enhanced pediatric surveillance, and structured visits
Group XVI: Group 1- GoatExperimental Treatment4 Interventions
Clinic-based visit, usual care, standard pediatric surveillance, and structured visits
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual care
2011
Completed Phase 4
~23770
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,688,805 Total Patients Enrolled
6 Trials studying Health Behaviors
12,235 Patients Enrolled for Health Behaviors
Boston Medical CenterLead Sponsor
382 Previous Clinical Trials
869,097 Total Patients Enrolled
2 Trials studying Health Behaviors
165 Patients Enrolled for Health Behaviors
Emily Feinberg, ScD, CPNPPrincipal InvestigatorBoston Medical Center and Boston University SPH
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child is between 3-12 years old and tested positive on the SWYC.My child is between 3-12 years old and has emotional or behavioral issues.My child is between 3-12 years old and has behavioral health concerns noted by a doctor.My child is currently seeing a specialist for behavioral health and doesn't need new services.My child does not have active psychosis.My child needs urgent help for a mental health issue.
Research Study Groups:
This trial has the following groups:- Group 1: Group 2- Cow
- Group 2: Group 3- Horse
- Group 3: Group 8- Dog
- Group 4: Group 9- Donkey
- Group 5: Group 12- Lion
- Group 6: Group 14- Zebra
- Group 7: Group 15- Elephant
- Group 8: Group 16- Giraffe
- Group 9: Group 13- Monkey
- Group 10: Group 5- Sheep
- Group 11: Group 10- Bear
- Group 12: Group 1- Goat
- Group 13: Group 4- Pig
- Group 14: Group 7- Cat
- Group 15: Group 11- Tiger
- Group 16: Group 6- Llama
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the desired results of this experiment?
"This clinical trial, tracked over 12 months, aims to gauge the efficacy of this intervention. Secondary objectives for assessment include patient retention rate concerning psychotherapeutic and/or pharmacological services (measured by ≥4 visits or resolution of service need in electronic health records), satisfaction with care as assessed through the SHCQ questionnaire, and changes detected in help-seeking attitudes & intentions via the PATPSI Inventory (scored on a 0-5 scale)."
Answered by AI
Am I eligible to participate in this research endeavor?
"This study needs 304 individuals with behaviorial health issues, aged between 3 and 12. Eligibility is determined via the Survey of Wellbeing of Young Children (3-5 years old) or Pediatric Symptom Checklist-17 (6-12 year olds), as well parental reports during paedatric visits."
Answered by AI
Does this research endeavor accept people younger than fifty years old?
"According to the conditions for participation, individuals between 3 and 12 years old are eligible. Meanwhile, 25 trials require participants aged below 18, while 53 studies ask for senior citizen involvement."
Answered by AI
How many individuals are actively participating in the research program?
"Affirmative. Details available on clinicaltrials.gov demonstrate that this medical trial is presently recruiting participants, with an initial posting date of June 24th 2019 and a recent update in May 20th 2022. This study requires 304 individuals to be admitted at 1 research site."
Answered by AI
Is this experiment recruiting participants currently?
"Affirmative. The information available on clinicaltrials.gov confirms that this medical investigation is currently recruiting patients, with the initial posting being made on June 24th 2019 and most recently updated in May 2022. A total of 304 participants need to be enrolled from 1 distinct site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger